Inspecs Group Plc SPEC
LSE · United Kingdom · Health Technology
GBp 91.00-2.50 (-2.67%)
Market open· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Despite currency headwinds, the Italian eyewear group strengthened its portfolio, improved margins, and delivered solid cash generation in the first quarter.
The London markets have recently been under pressure, with the FTSE 100 index closing lower due to weak trade data from China, highlighting ongoing challenges in global economic recovery. In such fluctuating market conditions, investors often look for opportunities that balance affordability with growth potential. Penny stocks, though an outdated term, still represent smaller or newer companies that can offer significant value when backed by strong financials.
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader:Investec Bank plc(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeInspecs Group plc (c) Name of the party to the offer with which exempt principal trader is connected:Inves
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.